RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Baris, D., Brown, L., Andreotti, G., & Devesa, S. S. (2013). Epidemiology of multiple myeloma. In P. H. Wiernik (Ed.), Neoplastic diseases of the blood (5th ed., pp. 547-564). Springer.
Home Neoplastic Diseases of the Blood Chapter Epidemiology of Multiple Myeloma Download book PDF Download book EPUB Epidemiology of Multiple Myeloma Dalsu Baris M.D., Ph.D., Linda Morris Brown M.P.H., Dr.P.H., Gabriella Andreotti Ph.D., M.P.H. & Susan S. Devesa Ph.D. Chapter First Online: 01 January 2012 2884 Accesses
4 Citations
Abstract Multiple myeloma, a plasma cell tumor arising in the bone marrow, is a rare cancer with an elusive etiology. In the USA, myeloma is estimated to account for approximately 1.3 % of all diagnosed cancers and 1.9 % of all cancer deaths [1]. According to estimates provided by the American Cancer Society, approximately 11,170 men and 9,010 women were expected to develop multiple myeloma, and 5,760 men and 4,890 women were expected to die from myeloma in the USA during 2010 [1]. The lifetime risk of being diagnosed with myeloma in the USA is 1.09 % for black men, 0.68 % for white men, 1.08 % for black women, and 0.51 % for white women [2].
